Laddar...
Delivery of Oligonucleotides to the Liver with GalNAc: From Research to Registered Therapeutic Drug
Targeted delivery of oligonucleotides to liver hepatocytes using N-acetylgalactosamine (GalNAc) conjugates that bind to the asialoglycoprotein receptor has become a breakthrough approach in the therapeutic oligonucleotide field. This technology has led to the approval of givosiran for the treatment...
Sparad:
| I publikationen: | Mol Ther |
|---|---|
| Huvudupphovsmän: | , , , , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
American Society of Gene & Cell Therapy
2020
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7403466/ https://ncbi.nlm.nih.gov/pubmed/32592692 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ymthe.2020.06.015 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|